Polaris Wealth Advisory Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-26
Closed -$9K – 171
2018
Q3
$9K Hold
26
– – ﹤0.01% 409
2018
Q2
$7K Hold
26
– – ﹤0.01% 212
2018
Q1
$7K Buy
+26
New +$8.07K ﹤0.01% 380
2015
Q3
– Sell
-1,315
Closed -$531K – 69
2015
Q2
$531K Buy
1,315
+70
+6% +$28.1K 0.11% 55
2015
Q1
$526K Sell
1,245
-240
-16% -$94.6K 0.1% 67
2014
Q4
$504K Buy
+1,485
New +$480K 0.1% 65

Other funds holding BIIB

Polaris Wealth Advisory Group's BIIB Position: Q4 2018 in Review

Polaris Wealth Advisory Group sold out of Biogen (BIIB) in Q4 2018, closing a stake of 26 shares — an estimated $9K sold.

Polaris Wealth Advisory Group first reported a position in BIIB in Q4 2014 and held it in 6 quarters. The position peaked at $531K in Q2 2015. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Polaris Wealth Advisory Group reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Polaris Wealth Advisory Group sold 26 Biogen shares in Q4 2018, an estimated $9K.
  • Polaris Wealth Advisory Group first reported a position in Biogen in Q4 2014 and held it in 6 quarters.
  • Polaris Wealth Advisory Group's Biogen position peaked at $531K in Q2 2015.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Polaris Wealth Advisory Group's 13F filing for Q4 2018, filed 17 Jan 2019.